Ludartin
Ludartin a sesquiterpene lactone, which can be isolated from the plant Artemisia carruthii Wood. Ludartin reduces the expression of myeloperoxidase and malondialdehyde, enhances the expression of glutathione and superoxide dismutase in spinal cord tissue. Ludartin inhibits neuronal apoptosis. Ludartin inhibits the upregulation of tumor necrosis factor-α, interleukin-1β, and interleukin-6. Ludartin improves the motor function of rats with spinal cord injury.
For research use only. We do not sell to patients.
- CAS No.: 36149-87-8
- Formula: C15H18O3
- Molecular Weight:246.30
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-431 | IC50 |
19 μM
Compound: Ludartin
|
Cytotoxicity against human A431 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Cytotoxicity against human A431 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 31784199] |
| A549 | IC50 |
25.18 μM
Compound: Ludartin
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31784199] |
| A549 | IC50 |
7.4 μM
Compound: 1
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
|
[PMID: 23886685] |
| A549 | IC50 |
7.4 μM
Compound: 1
|
Cytotoxicity against human A549 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
Cytotoxicity against human A549 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
|
[PMID: 24484897] |
| B16-F10 | IC50 |
6.6 μM
Compound: Ludartin
|
Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 31784199] |
| BHY | IC50 |
25.18 μM
Compound: Ludartin
|
Antiproliferative activity against human BHY cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human BHY cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31784199] |
| COLO 205 | IC50 |
25.18 μM
Compound: Ludartin
|
Antiproliferative activity against human COLO205 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human COLO205 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31784199] |
| HCT-116 | IC50 |
6.9 μM
Compound: 1
|
Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
|
[PMID: 23886685] |
| HCT-116 | IC50 |
6.9 μM
Compound: 1
|
Cytotoxicity against human HCT116 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
Cytotoxicity against human HCT116 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
|
[PMID: 24484897] |
| MCF7 | IC50 |
0.5 μM
Compound: 1
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
|
[PMID: 24484897] |
| MCF7 | IC50 |
25.18 μM
Compound: Ludartin
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31784199] |
| MIA PaCa-2 | IC50 |
25.18 μM
Compound: Ludartin
|
Antiproliferative activity against human MIAPaCa2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MIAPaCa2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31784199] |
| PC-3 | IC50 |
7.5 μM
Compound: 1
|
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
|
[PMID: 23886685] |
| PC-3 | IC50 |
7.5 μM
Compound: 1
|
Cytotoxicity against human PC3 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
Cytotoxicity against human PC3 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
|
[PMID: 24484897] |
| T98G | IC50 |
6.3 μM
Compound: 1
|
Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
|
[PMID: 24484897] |
| THP-1 | IC50 |
3.1 μM
Compound: 1
|
Cytotoxicity against human THP1 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human THP1 cells assessed as cell growth inhibition after 48 hrs by sulphorhodamine B assay
|
[PMID: 23886685] |
| THP-1 | IC50 |
3.1 μM
Compound: 1
|
Cytotoxicity against human THP1 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
Cytotoxicity against human THP1 cells assessed as growth inhibition by colorimetric sulphorhodamine B assay
|
[PMID: 24484897] |
Chemical Information
-
CAS No. 36149-87-8
-
Molecular Weight 246.30
-
Formula C15H18O3
-
SMILES
C[C@]12[C@]3([H])[C@]4([H])[C@](CCC(C)=C3C[C@@]1([H])O2)([H])C(C(O4)=O)=C
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)